These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 24816846)
21. Human astrocytic cells support persistent coxsackievirus B3 infection. Zhang X; Zheng Z; Shu B; Liu X; Zhang Z; Liu Y; Bai B; Hu Q; Mao P; Wang H J Virol; 2013 Nov; 87(22):12407-21. PubMed ID: 24027313 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis. Zhou L; He X; Gao B; Xiong S J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170 [TBL] [Abstract][Full Text] [Related]
23. Interferon-beta expression and type I interferon receptor signaling of hepatocytes prevent hepatic necrosis and virus dissemination in Coxsackievirus B3-infected mice. Koestner W; Spanier J; Klause T; Tegtmeyer PK; Becker J; Herder V; Borst K; Todt D; Lienenklaus S; Gerhauser I; Detje CN; Geffers R; Langereis MA; Vondran FWR; Yuan Q; van Kuppeveld FJM; Ott M; Staeheli P; Steinmann E; Baumgärtner W; Wacker F; Kalinke U PLoS Pathog; 2018 Aug; 14(8):e1007235. PubMed ID: 30075026 [TBL] [Abstract][Full Text] [Related]
24. FTY720 alleviates coxsackievirus B3-induced myocarditis and inhibits viral replication through regulating sphingosine 1-phosphate receptors and AKT/caspase-3 pathways. Wang X; Li M; Yu Y; Liu G; Yu Y; Zou Y; Ge J; Chen R J Cell Physiol; 2019 Aug; 234(10):18029-18040. PubMed ID: 30843214 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of IL-2 inducible T-cell kinase alleviates T-cell activation and murine myocardial inflammation associated with CVB3 infection. He F; Yao H; Xiao Z; Han J; Zou J; Liu Z Mol Immunol; 2014 May; 59(1):30-8. PubMed ID: 24462896 [TBL] [Abstract][Full Text] [Related]
26. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis. Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435 [TBL] [Abstract][Full Text] [Related]
27. α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis. Wu CY; Feng Y; Qian GC; Wu JH; Luo J; Wang Y; Chen GJ; Guo XK; Wang ZJ Clin Exp Immunol; 2010 Oct; 162(1):178-87. PubMed ID: 20726989 [TBL] [Abstract][Full Text] [Related]
28. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production. Fuse K; Chan G; Liu Y; Gudgeon P; Husain M; Chen M; Yeh WC; Akira S; Liu PP Circulation; 2005 Oct; 112(15):2276-85. PubMed ID: 16216974 [TBL] [Abstract][Full Text] [Related]
29. Th17 cells contribute to viral replication in coxsackievirus B3-induced acute viral myocarditis. Yuan J; Yu M; Lin QW; Cao AL; Yu X; Dong JH; Wang JP; Zhang JH; Wang M; Guo HP; Cheng X; Liao YH J Immunol; 2010 Oct; 185(7):4004-10. PubMed ID: 20802148 [TBL] [Abstract][Full Text] [Related]
30. PAR-1 contributes to the innate immune response during viral infection. Antoniak S; Owens AP; Baunacke M; Williams JC; Lee RD; Weithäuser A; Sheridan PA; Malz R; Luyendyk JP; Esserman DA; Trejo J; Kirchhofer D; Blaxall BC; Pawlinski R; Beck MA; Rauch U; Mackman N J Clin Invest; 2013 Mar; 123(3):1310-22. PubMed ID: 23391721 [TBL] [Abstract][Full Text] [Related]
31. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis. Henke A; Zell R; Ehrlich G; Stelzner A J Virol; 2001 Sep; 75(17):8187-94. PubMed ID: 11483764 [TBL] [Abstract][Full Text] [Related]
32. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas. Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635 [TBL] [Abstract][Full Text] [Related]
33. Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rbeta1 signaling and IFN-gamma increase inflammation in males independent from STAT4. Frisancho-Kiss S; Nyland JF; Davis SE; Frisancho JA; Barrett MA; Rose NR; Fairweather D Brain Res; 2006 Dec; 1126(1):139-47. PubMed ID: 16949558 [TBL] [Abstract][Full Text] [Related]
34. Role of neutrophils in CVB3 infection and viral myocarditis. Rivadeneyra L; Charó N; Kviatcovsky D; de la Barrera S; Gómez RM; Schattner M J Mol Cell Cardiol; 2018 Dec; 125():149-161. PubMed ID: 30393107 [TBL] [Abstract][Full Text] [Related]
35. STAT3 Increases CVB3 Replication and Acute Pancreatitis and Myocarditis Pathology via Impeding Nuclear Translocation of STAT1 and Interferon-Stimulated Gene Expression. Liang T; Zhang Z; Bai Z; Xu L; Xu W Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201692 [TBL] [Abstract][Full Text] [Related]
36. Protective role for interferon-beta in coxsackievirus B3 infection. Deonarain R; Cerullo D; Fuse K; Liu PP; Fish EN Circulation; 2004 Dec; 110(23):3540-3. PubMed ID: 15249500 [TBL] [Abstract][Full Text] [Related]
37. c-FLIP(S) reduces activation of caspase and NF-kappaB pathways and decreases T cell survival. Hinshaw-Makepeace J; Huston G; Fortner KA; Russell JQ; Holoch D; Swain S; Budd RC Eur J Immunol; 2008 Jan; 38(1):54-63. PubMed ID: 18081036 [TBL] [Abstract][Full Text] [Related]
39. Acetylation of FOXO1 activates Bim expression involved in CVB3 induced cardiomyocyte apoptosis. Hu Y; Yi L; Yang Y; Wu Z; Kong M; Kang Z; Yang Z Apoptosis; 2024 Aug; 29(7-8):1271-1287. PubMed ID: 38127284 [TBL] [Abstract][Full Text] [Related]
40. Coxsackievirus B3 induces viral myocarditis by upregulating toll-like receptor 4 expression. Zhao Z; Cai TZ; Lu Y; Liu WJ; Cheng ML; Ji YQ Biochemistry (Mosc); 2015 Apr; 80(4):455-62. PubMed ID: 25869363 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]